Minoru Kidokoro

1.2k total citations · 1 hit paper
33 papers, 966 citations indexed

About

Minoru Kidokoro is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Minoru Kidokoro has authored 33 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 11 papers in Immunology and 10 papers in Infectious Diseases. Recurrent topics in Minoru Kidokoro's work include Virology and Viral Diseases (20 papers), Virus-based gene therapy research (9 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Minoru Kidokoro is often cited by papers focused on Virology and Viral Diseases (20 papers), Virus-based gene therapy research (9 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Minoru Kidokoro collaborates with scholars based in Japan, United States and Vietnam. Minoru Kidokoro's co-authors include Hisatoshi Shida, Masato Tashiro, Makoto Takeda, Yuichiro Nakatsu, Masakazu Hatanaka, Hiroshi Katoh, Toru Kubota, Michio Morita, Shinji Harada and Mari Kannagi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Minoru Kidokoro

32 papers receiving 939 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells

1991 223 citations Mari Kannagi, Shinji Harada et al. International Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Minoru Kidokoro Japan	15	419	319	273	257	246	33	966
Grégory Caignard France	16	235 0.6×	404 1.3×	267 1.0×	253 1.0×	264 1.1×	35	827
Thomas Bean United Kingdom	6	461 1.1×	268 0.8×	612 2.2×	197 0.8×	113 0.5×	6	1000
Frédéric Delebecque France	13	532 1.3×	235 0.7×	430 1.6×	95 0.4×	77 0.3×	16	1.1k
Vanessa Contreras France	15	752 1.8×	408 1.3×	118 0.4×	303 1.2×	327 1.3×	35	1.3k
Maja A. Sommerfelt Norway	17	622 1.5×	548 1.7×	403 1.5×	182 0.7×	156 0.6×	43	1.6k
Lucilla Steinaa Kenya	16	275 0.7×	210 0.7×	82 0.3×	182 0.7×	235 1.0×	45	923
M E Andrew Australia	16	438 1.0×	159 0.5×	293 1.1×	93 0.4×	64 0.3×	20	803
Amanda Barnard United Kingdom	11	403 1.0×	110 0.3×	408 1.5×	207 0.8×	169 0.7×	16	929
Neil A. Bryant United Kingdom	17	239 0.6×	136 0.4×	726 2.7×	391 1.5×	57 0.2×	21	905
Robyn Washington Parks United States	13	627 1.5×	123 0.4×	172 0.6×	262 1.0×	237 1.0×	21	871

Countries citing papers authored by Minoru Kidokoro

Since Specialization

Citations

This map shows the geographic impact of Minoru Kidokoro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minoru Kidokoro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minoru Kidokoro more than expected).

Fields of papers citing papers by Minoru Kidokoro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minoru Kidokoro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minoru Kidokoro. The network helps show where Minoru Kidokoro may publish in the future.

Co-authorship network of co-authors of Minoru Kidokoro

This figure shows the co-authorship network connecting the top 25 collaborators of Minoru Kidokoro. A scholar is included among the top collaborators of Minoru Kidokoro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minoru Kidokoro. Minoru Kidokoro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kato, Fumihiro, Yuichiro Nakatsu, Toru Kubota, et al.. (2021). Antiviral Activity of CD437 Against Mumps Virus. Frontiers in Microbiology. 12. 751909–751909. 5 indexed citations

Katoh, Hiroshi, Tsuyoshi Sekizuka, Yuichiro Nakatsu, et al.. (2019). The R2TP complex regulates paramyxovirus RNA synthesis. PLoS Pathogens. 15(5). e1007749–e1007749. 13 indexed citations

Kidokoro, Minoru, Tomomi Kitamura, Yoshio Mori, et al.. (2019). Seroprevalence of mumps before the introduction of mumps-containing vaccine in Lao PDR: results from a nationwide cross-sectional population-based survey. BMC Research Notes. 12(1). 155–155. 1 indexed citations

Kidokoro, Minoru. (2019). Future perspectives of mumps vaccine. Uirusu. 68(2). 125–136. 2 indexed citations

Katoh, Hiroshi, Toru Kubota, Yuichiro Nakatsu, et al.. (2017). Heat Shock Protein 90 Ensures Efficient Mumps Virus Replication by Assisting with Viral Polymerase Complex Formation. Journal of Virology. 91(6). 49 indexed citations

Nagita, Akira, et al.. (2015). Virus genotypes and responses of serum-specific antibodies in children with primary mumps and mumps reinfection. Pediatric Research. 78(5). 580–584. 4 indexed citations

Katoh, Hiroshi, Yuichiro Nakatsu, Toru Kubota, et al.. (2015). Mumps Virus Is Released from the Apical Surface of Polarized Epithelial Cells, and the Release Is Facilitated by a Rab11-Mediated Transport System. Journal of Virology. 89(23). 12026–12034. 27 indexed citations

Sato, Hirotaka, Jing Chen, Keitaro Matsuo, et al.. (2013). Immunogenicity and safety of the vaccinia virus LC16m8Δ vector expressing SIV Gag under a strong or moderate promoter in a recombinant BCG prime-recombinant vaccinia virus boost protocol. Vaccine. 31(35). 3549–3557. 13 indexed citations

Suzuki, Hajime, Minoru Kidokoro, Ismaël Fofana, et al.. (2009). Immunogenicity of newly constructed attenuated vaccinia strain LC16m8Δ that expresses SIV Gag protein. Vaccine. 27(7). 966–971. 5 indexed citations

10.

Yasui, Fumihiko, Chieko Kai, Masahiro Kitabatake, et al.. (2008). Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV. The Journal of Immunology. 181(9). 6337–6348. 187 indexed citations

11.

Kidokoro, Minoru, et al.. (2006). Development and biological properties of a new live attenuated mumps vaccine. Comparative Immunology Microbiology and Infectious Diseases. 29(2-3). 89–99. 5 indexed citations

12.

Kitabatake, Masahiro, Shingo Inoue, Fumihiko Yasui, et al.. (2006). SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus. Vaccine. 25(4). 630–637. 19 indexed citations

13.

Nakatsu, Yuichiro, Makoto Takeda, Minoru Kidokoro, Michinori Kohara, & Yusuke Yanagi. (2006). Rescue system for measles virus from cloned cDNA driven by vaccinia virus Lister vaccine strain. Journal of Virological Methods. 137(1). 152–155. 19 indexed citations

14.

Kidokoro, Minoru, et al.. (2002). Large-scale preparation of biologically active measles virus haemagglutinin expressed by attenuated vaccinia virus vectors. Microbes and Infection. 4(10). 1035–1044. 9 indexed citations

15.

Kidokoro, Minoru, et al.. (2001). Pathogenicity of mumps virus in the marmoset. Journal of Medical Virology. 66(1). 115–122. 14 indexed citations

16.

Nakamura, Yoshimi, et al.. (1994). Expression of CD33 antigen on normal human activated T lymphocytes [letter]. Blood. 83(5). 1442–1443. 16 indexed citations

17.

Takayama, Naohide, et al.. (1992). Immunization of Healthy Children with Measles-Mumps-Rubella Trivalent Vaccine Simultaneously Given with Varicella Vaccine. Kansenshogaku zasshi. 66(6). 776–780. 4 indexed citations

18.

Nakamura, Yoshihiko, Yutaka Tokuda, Hideo Tsukamoto, et al.. (1992). Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy. British Journal of Cancer. 66(1). 20–26. 12 indexed citations

19.

Kannagi, Mari, Shinji Harada, Ikuro Maruyama, et al.. (1991). Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. International Immunology. 3(8). 761–767. 223 indexed citations breakdown →

20.

Suzuki, Kota, Masashi Morita, Minoru Kidokoro, et al.. (1990). Development and evaluation of the TD97 measles virus vaccine. Journal of Medical Virology. 32(3). 194–201. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact